Harvest Fund Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.48M | Sell |
29,791
-7,366
| -20% | -$1.63M | 0.28% | 69 |
|
|
2025
Q4 | $8.49M | Sell |
37,157
-2,196
| -6% | -$500K | 0.32% | 65 |
|
|
2025
Q3 | $9.11M | Buy |
39,353
+10,588
| +37% | +$2.16M | 0.39% | 49 |
|
|
2025
Q2 | $5.34M | Sell |
28,765
-16,161
| -36% | -$3M | 0.25% | 79 |
|
|
2025
Q1 | $9.41M | Buy |
44,926
+36,851
| +456% | +$7.16M | 0.47% | 43 |
|
|
2024
Q4 | $1.44M | Sell |
8,075
-14,936
| -65% | -$2.75M | 0.07% | 174 |
|
|
2024
Q3 | $4.54M | Buy |
23,011
+3,729
| +19% | +$696K | 0.27% | 68 |
|
|
2024
Q2 | $3.3M | Sell |
19,282
-742
| -4% | -$123K | 0.24% | 65 |
|
|
2024
Q1 | $3.64M | Buy |
20,024
+18,544
| +1,253% | +$3.2M | 0.33% | 59 |
|
|
2023
Q4 | $229K | Sell |
1,480
-3,982
| -73% | -$581K | 0.04% | 216 |
|
|
2023
Q3 | $814K | Sell |
5,462
-731
| -12% | -$107K | 0.14% | 84 |
|
|
2023
Q2 | $834K | Sell |
6,193
-9,798
| -61% | -$1.44M | 0.17% | 72 |
|
|
2023
Q1 | $2.55M | Sell |
15,991
-1,209
| -7% | -$185K | 0.56% | 33 |
|
|
2022
Q4 | $2.78M | Buy |
17,200
+2,742
| +19% | +$420K | 0.72% | 31 |
|
|
2022
Q3 | $1.94M | Sell |
14,458
-2,650
| -15% | -$380K | 0.56% | 36 |
|
|
2022
Q2 | $2.63M | Buy |
17,108
+1,410
| +9% | +$215K | 0.73% | 28 |
|
|
2022
Q1 | $2.54M | Buy |
15,698
+6,936
| +79% | +$1.01M | 0.53% | 27 |
|
|
2021
Q4 | $1.19M | Buy |
8,762
+2,235
| +34% | +$264K | 0.2% | 48 |
|
|
2021
Q3 | $703K | Sell |
6,527
-3,409
| -34% | -$390K | 0.16% | 51 |
|
|
2021
Q2 | $1.14M | Buy |
9,936
+432
| +5% | +$48.7K | 0.12% | 47 |
|
|
2021
Q1 | $1.03M | Sell |
9,504
-464
| -5% | -$49.6K | 0.1% | 49 |
|
|
2020
Q4 | $1.07M | Sell |
9,968
-518
| -5% | -$49.8K | 0.09% | 46 |
|
|
2020
Q3 | $922K | Sell |
10,486
-1,513
| -13% | -$142K | 0.08% | 54 |
|
|
2020
Q2 | $1.19M | Buy |
11,999
+2,260
| +23% | +$199K | 0.11% | 37 |
|
|
2020
Q1 | $739K | Buy |
9,739
+2,228
| +30% | +$190K | 0.09% | 44 |
|
|
2019
Q4 | $670K | Buy |
7,511
+2,732
| +57% | +$227K | 0.07% | 48 |
|
|
2019
Q3 | $362K | Buy |
4,779
+2,363
| +98% | +$162K | 0.05% | 71 |
|
|
2019
Q2 | $176K | Sell |
2,416
-975
| -29% | -$76.6K | 0.02% | 127 |
|
|
2019
Q1 | $273K | Sell |
3,391
-3,950
| -54% | -$323K | 0.05% | 88 |
|
|
2018
Q4 | $677K | Buy |
7,341
+1,269
| +21% | +$112K | 0.14% | 41 |
|
|
2018
Q3 | $574K | Buy |
6,072
+3,265
| +116% | +$310K | 0.1% | 54 |
|
|
2018
Q2 | $260K | Hold |
2,807
| – | – | 0.04% | 63 |
|
|
2018
Q1 | $265K | Buy |
2,807
+757
| +37% | +$83.2K | 0.04% | 58 |
|
|
2017
Q4 | $198K | Sell |
2,050
-177
| -8% | -$16.7K | 0.03% | 64 |
|
|
2017
Q3 | $198K | Hold |
2,227
| – | – | 0.03% | 60 |
|
|
2017
Q2 | $161K | Buy |
2,227
+2,052
| +1,173% | +$138K | 0.02% | 76 |
|
|
2017
Q1 | $11K | Hold |
175
| – | – | ﹤0.01% | 203 |
|
|
2016
Q4 | $11K | Buy |
+175
| New | +$10.7K | ﹤0.01% | 209 |
|
Other funds holding ABBV
VCM
VPM
Harvest Fund Management's ABBV Position: Q1 2026 in Review
Harvest Fund Management reduced its AbbVie (ABBV) stake by 20% in Q1 2026, selling an estimated $1.63M and leaving 29,791 shares worth $6.48M. The position accounts for 0.28% of the portfolio, ranked #69.
Harvest Fund Management first reported a position in ABBV in Q4 2016 and has held it in 38 quarters since. The position peaked at $9.41M in Q1 2025. 4,078 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Harvest Fund Management held 29,791 shares of AbbVie worth $6.48M as of Q1 2026.
- Harvest Fund Management sold 7,366 AbbVie shares in Q1 2026, an estimated $1.63M.
- AbbVie made up 0.28% of Harvest Fund Management's portfolio in Q1 2026, its #69 holding.
- Harvest Fund Management first reported a position in AbbVie in Q4 2016 and has held it in 38 quarters since.
- Harvest Fund Management's AbbVie position peaked at $9.41M in Q1 2025.
- 4,078 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Harvest Fund Management's 13F filing for Q1 2026, filed 14 May 2026.